Q2 EPS Forecast for iTeos Therapeutics Lowered by Analyst
iTeos Therapeutics, Inc. (NASDAQ:ITOS – Free Report) – Analysts at Leerink Partnrs dropped their Q2 2025 earnings per share (EPS) estimates for iTeos Therapeutics in a report issued on Wednesday, May 28th. Leerink Partnrs analyst D. Graybosch now anticipates that the company will post earnings of ($0.84) per share for the quarter, down from their […]
iTeos Therapeutics, Inc. (NASDAQ:ITOS – Free Report) – Analysts at Leerink Partnrs dropped their Q2 2025 earnings per share (EPS) estimates for iTeos Therapeutics in a report issued on Wednesday, May 28th. Leerink Partnrs analyst D. Graybosch now anticipates that the company will post earnings of ($0.84) per share for the quarter, down from their […]
